Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 352

1.

14th International Symposium on Thrombolysis, Thrombectomy and Acute Stroke Therapy: Proceedings and summary of discussions.

Sheth SA, Lopez-Rivera V, Lee S, Savitz SI, Liebeskind DS, Grotta JC; Thrombolysis, Thrombectomy and Acute Stroke Therapy (TTST) group.

Int J Stroke. 2019 Mar 28:1747493019838760. doi: 10.1177/1747493019838760. [Epub ahead of print]

PMID:
30920353
2.

Interhospital Transfer of Stroke Patients for Endovascular Treatment.

Grotta JC.

Circulation. 2019 Mar 26;139(13):1578-1580. doi: 10.1161/CIRCULATIONAHA.118.039425. No abstract available.

PMID:
30908102
3.

Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.

Alexandrov AV, Köhrmann M, Soinne L, Tsivgoulis G, Barreto AD, Demchuk AM, Sharma VK, Mikulik R, Muir KW, Brandt G, Alleman J, Grotta JC, Levi CR, Molina CA, Saqqur M, Mavridis D, Psaltopoulou T, Vosko M, Fiebach JB, Mandava P, Kent TA, Alexandrov AW, Schellinger PD; CLOTBUST-ER Trial Investigators.

Lancet Neurol. 2019 Apr;18(4):338-347. doi: 10.1016/S1474-4422(19)30026-2.

PMID:
30878103
4.

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack.

Wang Y, Johnston SC, Bath PM, Grotta JC, Pan Y, Amarenco P, Wang Y, Simon T, Kim JS, Jeng JS, Liu L, Lin Y, Wong KSL, Wang D, Li H.

BMJ. 2019 Feb 28;364:l895. doi: 10.1136/bmj.l895. No abstract available.

5.

Real-World Treatment Trends in Endovascular Stroke Therapy.

Saber H, Navi BB, Grotta JC, Kamel H, Bambhroliya A, Vahidy FS, Chen PR, Blackburn S, Savitz SI, McCullough L, Sheth SA.

Stroke. 2019 Mar;50(3):683-689. doi: 10.1161/STROKEAHA.118.023967.

PMID:
30726185
6.

Endovascular Thrombectomy for Mild Strokes: How Low Should We Go?

Sarraj A, Hassan A, Savitz SI, Grotta JC, Cai C, Parsha KN, Farrell CM, Imam B, Sitton CW, Reddy ST, Kamal H, Goyal N, Elijovich L, Reishus K, Krishnan R, Sangha N, Wu A, Costa R, Malik R, Mir O, Hasan R, Snodgrass LM, Requena M, Graybeal D, Abraham M, Chen M, McCullough LD, Ribo M.

Stroke. 2018 Oct;49(10):2398-2405. doi: 10.1161/STROKEAHA.118.022114.

PMID:
30355094
7.

Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study).

Berekashvili K, Soomro J, Shen L, Misra V, Chen PR, Blackburn S, Dannenbaum M, Grotta JC, Barreto AD.

J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3647-3651. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.036. Epub 2018 Sep 21.

PMID:
30249518
8.

Intraosseous Administration of Tissue Plasminogen Activator on a Mobile Stroke Unit.

Bowry R, Nour M, Kus T, Parker S, Stephenson J, Saver J, Grotta JC, Ostermayer D.

Prehosp Emerg Care. 2018 Oct 25:1-6. doi: 10.1080/10903127.2018.1526355. [Epub ahead of print]

PMID:
30235055
9.

Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

Al-Shahi Salman R, Frantzias J, Lee RJ, Lyden PD, Battey TWK, Ayres AM, Goldstein JN, Mayer SA, Steiner T, Wang X, Arima H, Hasegawa H, Oishi M, Godoy DA, Masotti L, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Jang DK, Davalos A, Castillo J, Yao X, Claassen J, Volbers B, Kazui S, Okada Y, Fujimoto S, Toyoda K, Li Q, Khoury J, Delgado P, Sabín JÁ, Hernández-Guillamon M, Prats-Sánchez L, Cai C, Kate MP, McCourt R, Venkatasubramanian C, Diringer MN, Ikeda Y, Worthmann H, Ziai WC, d'Esterre CD, Aviv RI, Raab P, Murai Y, Zazulia AR, Butcher KS, Seyedsaadat SM, Grotta JC, Martí-Fàbregas J, Montaner J, Broderick J, Yamamoto H, Staykov D, Connolly ES, Selim M, Leira R, Moon BH, Demchuk AM, Di Napoli M, Fujii Y, Anderson CS, Rosand J; VISTA-ICH Collaboration; ICH Growth Individual Patient Data Meta-analysis Collaborators.

Lancet Neurol. 2018 Oct;17(10):885-894. doi: 10.1016/S1474-4422(18)30253-9. Epub 2018 Aug 14. Erratum in: Lancet Neurol. 2018 Sep 19;:.

10.

Transatlantic Differences in Management of Carotid Stenosis: BRIDGing the Gap in StrokE Management (BRIDGE) Project.

Balucani C, Arnedo V, Weedon J, Leys D, Mas JL, Brown M, Grotta JC, Gonzales NR, Hacke W, Brott T, Levine SR.

Neurohospitalist. 2018 Jul;8(3):113-123. doi: 10.1177/1941874417747772. Epub 2018 Jan 17.

PMID:
29977441
11.

To Treat or Not to Treat?

Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, Scott PA, Kim D, Balucani C.

Stroke. 2018 Aug;49(8):1933-1938. doi: 10.1161/STROKEAHA.118.020971.

PMID:
29976582
12.

Antiplatelet Therapy after Ischemic Stroke or TIA.

Grotta JC.

N Engl J Med. 2018 Jul 19;379(3):291-292. doi: 10.1056/NEJMe1806043. Epub 2018 May 16. No abstract available.

PMID:
29766754
13.

Time to Decision and Treatment With tPA (Tissue-Type Plasminogen Activator) Using Telemedicine Versus an Onboard Neurologist on a Mobile Stroke Unit.

Bowry R, Parker SA, Yamal JM, Hwang H, Appana S, Rangel-Gutierrez N, Wu TC, Rajan SS, Grotta JC.

Stroke. 2018 Jun;49(6):1528-1530. doi: 10.1161/STROKEAHA.117.020585. Epub 2018 May 2.

PMID:
29720439
14.

HeadPoST: Rightly positioned, or flat out wrong?

Alexandrov AW, Tsivgoulis G, Hill MD, Liebeskind DS, Schellinger P, Ovbiagele B, Arthur AS, Caso V, Nogueira RG, Hemphill JC 3rd, Grotta JC, Hacke W, Alexandrov AV.

Neurology. 2018 May 8;90(19):885-889. doi: 10.1212/WNL.0000000000005481. Epub 2018 Apr 11. Review.

PMID:
29643083
15.

Thrombelastography Suggests Hypercoagulability in Patients with Renal Dysfunction and Intracerebral Hemorrhage.

Meier K, Saenz DM, Torres GL, Cai C, Rahbar MH, McDonald M, Fraser S, Espino E, Choi HA, Edwards NJ, Lee K, Grotta JC, Chang TR.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1350-1356. doi: 10.1016/j.jstrokecerebrovasdis.2017.12.026. Epub 2018 Feb 12.

PMID:
29449126
16.

Bringing Emergency Neurology to Ambulances: Mobile Stroke Unit.

Bowry R, Grotta JC.

Semin Respir Crit Care Med. 2017 Dec;38(6):713-717. doi: 10.1055/s-0037-1607994. Epub 2017 Dec 20. Review.

PMID:
29262428
17.

Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.

Hacke W, Lyden P, Emberson J, Baigent C, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis SM, Donnan GA, Grotta JC, Howard G, Kaste M, Koga M, von Kummer R, Lansberg MG, Lindley RI, Olivot JM, Parsons M, Sandercock PA, Toni D, Toyoda K, Wahlgren N, Wardlaw JM, Whiteley WN, Del Zoppo G, Lees KR; Stroke Thrombolysis Trialists’ Collaborators Group.

Int J Stroke. 2018 Feb;13(2):175-189. doi: 10.1177/1747493017744464. Epub 2017 Nov 24. Erratum in: Int J Stroke. 2018 Feb;13(2):NP3.

PMID:
29171359
18.

Blood-brain barrier leakage increases with small vessel disease in acute ischemic stroke.

Arba F, Leigh R, Inzitari D, Warach SJ, Luby M, Lees KR; STIR/VISTA Imaging Collaboration.

Neurology. 2017 Nov 21;89(21):2143-2150. doi: 10.1212/WNL.0000000000004677. Epub 2017 Oct 25.

19.

Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke.

McDonald MM, Almaghrabi TS, Saenz DM, Cai C, Rahbar MH, Choi HA, Lee K, Grotta JC, Chang TR.

J Intensive Care Med. 2017 Jan 1:885066617729644. doi: 10.1177/0885066617729644. [Epub ahead of print]

PMID:
28931362
20.

Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".

Barreto AD, Grotta JC.

Stroke. 2017 Sep;48(9):e259. doi: 10.1161/STROKEAHA.117.018294. Epub 2017 Jul 28. No abstract available.

Supplemental Content

Loading ...
Support Center